Kento Umino

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 38 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +9

Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

Daisuke Minakata, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · International Journal of Hematology · 2018 · 37 citations

Medicine, Hematology, Pharmacology +12

Risk factors for high-dose methotrexate-induced nephrotoxicity

Shin‐ichiro Kawaguchi, Shin‐ichiro Fujiwara, Rui Murahashi et al. · International Journal of Hematology · 2021 · 27 citations

Pharmacy, Nephrology, Pharmacology +13

Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan

Miyuki Sugimoto, Shoko Ito, Kiyomi Mashima et al. · Annals of Hematology · 2016 · 26 citations

Medicine, Oncology, Chemotherapy +10

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama et al. · Blood · 2022 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +7